3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tobacco Use Disorder
5
Smoking Cessation
5
Smoking
4
Lung Neoplasms
4
Uterine Cervical Neoplasms
3
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Tobacco Use
2
Small Cell Lung Carcinoma
2
Head and Neck Neoplasms
2
Cigarette Smoking
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Tobacco Use Cessation
1
Tobacco Smoking
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Overweight
1
Oropharyngeal Neoplasms
1
Neoplasms, Second Primary
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Interventions
Radiotherapy
2
beta Carotene
1
avelumab
1
alpha-Tocopherol
1
Varenicline
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Surgical Procedures, Operative
1
Nicotine Chewing Gum
1
Leucovorin
1
Lenalidomide
1
Irinotecan
1
Fluorouracil
1
Drug Therapy
1
Cryosurgery
1
Choledochostomy
1
Cetuximab
1
Bupropion
1
Animal Assisted Therapy
1
Acupressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasms, Second Primary
×
Tobacco Use Cessation Devices
×
Clear all
NCT04634071
2026-02-02
TTOP
University of Kentucky
Phase 2
Completed
126 enrolled